calendar
8,756 catalysts · 3,153 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 584 earnings
8,756 catalysts · 3,153 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 584 earnings
Medline convenience kits containing Olympus biopsy valves: 1. BRONCH PACK, DYKE2096 2. NON MB BRONCHOPSCOPY CCH LH PK, DYNJT6182 3. PULMONARY BRONCH PACK, DYNDA2861A — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing
Convatec, EsteemBody Drainable Pouch REF:423657 10-35mm — Reason: Drainable large pouch may leak due to manufacturing issue. — Status: Ongoing
Medline kits containing Olympus biopsy valves: 1. BAL KIT, DYNDA2137B 2. ENDO KIT, DYKE1915 — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing
MEDLINE ANTERIOR HIP PACK DYNJ64672B — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing
NS grant. $494,240. PI: Suresh L Mehta
HG grant. $1,193,092. PI: Jada Benn Torres
HD grant. $50,526. PI: Cher Sha
NS grant. $128,358. PI: Giulia Carli
ES grant. $5,000,000. PI: Jineta Banerjee
HL grant. $247,600. PI: Cassandra Lucille Clift
HL grant. $249,000. PI: Lisandra Flores Aldama
GM grant. $75,880. PI: Kevin Jaime Gonzalez
DK grant. $75,520. PI: Katherine Lauren Kruckow
DK grant. $676,905. PI: Hai-Bin Ruan
HD grant. $49,538. PI: Charlotte Greenbaum
HL grant. $249,000. PI: Chengyi Tu
HG grant. $806,828. PI: David Martin McCandlish
AI grant. $403,320. PI: Antonius G Oomens
Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL
Sponsor: NATCO. Form: TABLET. Route: ORAL
Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL
Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL
Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION
Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL
Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL
Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL
Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: QILU. Form: INJECTABLE. Route: INJECTION
Product code: MQV. Advisory committee: Orthopedic. Type: Traditional
Product code: QEY. Advisory committee: Cardiovascular. Type: Special
Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional
Product code: MAI. Advisory committee: Orthopedic. Type: Traditional